Studies of surgically resected brain tissue from patients with treatment-resistant epilepsy have demonstrated reduced expression of claudin-5, with corresponding dynamic contrast-enhanced magnetic resonance imaging MCAO revealing significant BBB breakdown [81]. This evidence concerns the gene CLDN5 and epilepsy.